A significant shift in the country's drug policy has taken place, as the regulators announce the availability of psilocybin mushrooms for therapeutic treatment. Previously, these substances were heavily restricted, but a growing body of studies suggests they potentially offer relief for emotional illnesses like anxiety. This development represents